Insider Transactions in Q2 2022 at Willis Towers Watson PLC (WTW)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2022
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Michael P. Hammond Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 08
2022
|
Victor F Ganzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.6%
|
$26,752
$209.84 P/Share
|
|
Jun 08
2022
|
Fumbi F. Chima Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,574
+49.1%
|
-
|
|
Jun 08
2022
|
Fumbi F. Chima Director |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-48.21%
|
$11,286
$209.84 P/Share
|
|
Jun 08
2022
|
Brendan R Oneill Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+6.46%
|
-
|
|
Jun 08
2022
|
Michelle R Swanback Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Michelle R Swanback Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 08
2022
|
Linda D Rabbitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,574
+9.19%
|
-
|
|
Jun 08
2022
|
Paul D Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+10.48%
|
-
|
|
Jun 08
2022
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Inga K Beale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.45%
|
$294,000
$210.67 P/Share
|
|
May 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Bona fide gift
|
Indirect |
1,205
+15.3%
|
-
|
|
May 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Bona fide gift
|
Direct |
1,205
-1.61%
|
-
|
|
May 11
2022
|
Anna C Catalano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-4.64%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Wendy E Lane Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-3.67%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Linda D Rabbitt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-3.57%
|
$106,708
$206.35 P/Share
|
|
May 11
2022
|
Paul D Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-2.59%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Victor F Ganzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
791
-3.55%
|
$162,946
$206.35 P/Share
|
|
May 11
2022
|
Wilhelm Zeller Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+3.01%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Brendan R Oneill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-2.18%
|
$59,946
$206.35 P/Share
|
|
May 02
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,000
-3.38%
|
$428,000
$214.1 P/Share
|
|
May 02
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-0.71%
|
$299,600
$214.34 P/Share
|
|
Apr 01
2022
|
Fumbi F. Chima Director |
BUY
Grant, award, or other acquisition
|
Direct |
112
+50.0%
|
-
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
694
+21.21%
|
-
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
480
-20.3%
|
$108,960
$227.62 P/Share
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
480
+16.87%
|
-
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+34.92%
|
-
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,014
-53.68%
|
$230,178
$227.62 P/Share
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
1,014
+34.93%
|
-
|
|
Apr 01
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
1,026
+1.35%
|
-
|
|
Apr 01
2022
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+7.33%
|
-
|
|
Apr 01
2022
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
105
+20.15%
|
-
|
|
Apr 01
2022
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,684
+9.86%
|
-
|
|
Apr 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
1,197
+1.2%
|
-
|
|
Apr 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.42%
|
$330,400
$236.88 P/Share
|
|
Apr 01
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
1,197
+7.86%
|
-
|
|
Apr 01
2022
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
931
+3.37%
|
-
|
|
Apr 01
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+6.17%
|
-
|
|
Apr 01
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+12.04%
|
-
|